CD22ΔE12 as a molecular target for RNAi therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|169|3|401-414

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.169, Iss.3, 2015-05, pp. : 401-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assignment of porcine CD97 gene to the 1/2q21→q22 region of the pig chromosome 2 with somatic cell hybrids

By  

Cytogenetic and Genome Research, Vol. 103, Iss. 1-2, 2004-03 ,pp. : 203H-

Karger

Access to resources Recommend Favorite

Uterine metastasis of lung adenocarcinoma under molecular target therapy with epidermal growth factor receptor tyrosine kinase inhibitors: A case report and review of the literature

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 44, Iss. 2, 2018-02 ,pp. : 352-358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of CD22 expression in acute lymphoblastic leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 964-969

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD22 serves as a receptor for soluble IgM

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 42, Iss. 1, 2012-01 ,pp. : 241-247

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Proteasome, a New Target for Cancer Therapy

By  

Oncology Research and Treatment, Vol. 25, Iss. 6, 2003-01 ,pp. : 534-539

Karger

Access to resources Recommend Favorite